Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Feb 2010 12:50

RNS Number : 4556G
Minster Pharmaceuticals PLC
01 February 2010
 



 

 

For immediate release

1 February 2010

 

 

 

Minster Pharmaceuticals plc

("Minster" or the "Company")

 

 

Minster Pharmaceuticals plc (AIM: MPM), the drug development company specialising in neurological and psychiatric disorders, announces that further to the announcement made on 4 January 2010 regarding Peter Blower's intention to resign as a director of Minster on 31 January 2010, the Company has received notice of Mr Blower's resignation as a director with effect from 31 January 2010.

 

John Russell, Minster's Chairman, said: "We are grateful to Peter for his very significant contribution to Minster as an executive director over the last five years."

 

 

 

Enquiries

Minster Pharmaceuticals plc

Phone: +44 (0)20 7936 9921

John Russell, Chairman and Interim CEO

Karl Keegan, Chief Financial Officer

Buchanan Communications

Phone: +44 (0)20 7466 5000

Mark Court

Nomura Code Securities Limited

(Rule 3 Advisers & NOMAD)

Phone: +44 (0)20 7776 1200

Richard Potts, Giles Balleny

 

 

 

Dealing Disclosure Requirements

 

Under the provisions of the Rule 8.3 of the City Code, if any person is, or becomes, "interested" (directly or indirectly) in one per cent. or more of any class of "relevant securities" of Minster, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30 p.m. (London Time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Minster, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the City Code, all "dealings" in "relevant securities" of Minster by Proximagen or Minster, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London Time) on the London business day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

 

"Interest in securities" arises, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having as "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the City Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGZZMRGGZM
Date   Source Headline
4th Dec 20196:17 pmRNSStatement re Creditors' Voluntary Liquidation
20th Nov 20196:00 pmRNSMporium Group
20th Nov 20194:43 pmRNSAppointment of Administrator for Mporium Ltd
20th Nov 20193:03 pmRNSResignation of NOMAD
21st Oct 20197:30 amRNSSuspension - Mporium Group PLC
21st Oct 20197:00 amRNSAdjournment of GM & suspension of trading
30th Sep 20197:01 amRNSProposed acquisition and fundraising
30th Sep 20197:00 amRNSHalf-year Results
26th Sep 20192:00 pmRNSPrice Monitoring Extension
19th Sep 20194:29 pmRNSBlock Admission Six Monthly Return
4th Sep 20197:00 amRNSCommercial Partnership with Click Labs Group
28th Aug 20197:00 amRNSCommercial agreement w/ major media agency network
20th Aug 201911:04 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHolding(s) in Company
15th Aug 20199:20 amRNSIssue of Shares, Warrants and Total Voting Rights
12th Aug 201912:02 pmRNSHolding(s) in Company
30th Jul 20197:00 amRNSPCA Dealing
24th Jul 201910:33 amRNSResult of AGM
23rd Jul 20197:00 amRNSDirectorate Changes and Update on Strategy
11th Jul 20197:00 amRNSSale of Fast Web Media
2nd Jul 20195:36 pmRNSResult of GM - Replacement
2nd Jul 20193:30 pmRNSResult of GM
28th Jun 20197:00 amRNSFinal Results
14th Jun 20197:00 amRNSUpdate on Fundraising and Posting of Circular
11th Jun 201911:05 amRNSSecond Price Monitoring Extn
11th Jun 201911:00 amRNSPrice Monitoring Extension
11th Jun 20197:23 amRNSFundraising, Update on FY results & Biz Structure
3rd Jun 20193:00 pmRNSUpdate on Report and Accounts
15th May 20192:59 pmRNSBlock Listing Return
4th Apr 20197:00 amRNSQ1 Update
20th Mar 20197:00 amRNSContract extension for MporiumX
13th Mar 20192:34 pmRNSHolding(s) in Company
13th Mar 20197:00 amRNSNew agreement for IMPACT
20th Feb 20198:20 amRNSHolding(s) in Company
18th Feb 201912:14 pmRNSHolding(s) in Company
15th Feb 20191:47 pmRNSHolding(s) in Company
15th Feb 201910:39 amRNSHolding(s) in Company
15th Feb 201910:35 amRNSHolding(s) in Company
15th Feb 201910:32 amRNSHolding(s) in Company
15th Feb 201910:25 amRNSHolding(s) in Company
12th Feb 20194:40 pmRNSSecond Price Monitoring Extn
12th Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSUpdate on Revenue and the Allay Agreement
11th Feb 201910:04 amRNSResult of General Meeting
8th Feb 20197:00 amRNSNew Agreement for MporiumX
30th Jan 20194:40 pmRNSSecond Price Monitoring Extn
30th Jan 20194:35 pmRNSPrice Monitoring Extension
25th Jan 20197:00 amRNSStrategic Collaboration Agreement & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.